A randomized, double-blind, placebo-controlled, multiple dose study to evaluate the safety, tolerability, pharmacokinetics, and efficacy of systemic AMG 108 [MEDI 8968] in subjects with osteoarthritis (OA).
Phase of Trial: Phase II
Latest Information Update: 29 Jul 2011
At a glance
- Drugs MEDI 8968 (Primary)
- Indications Osteoarthritis
- Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
- 29 Jul 2011 Primary endpoint 'Western-Ontario-and-McMaster-Universities-Osteoarthritis-Index' has not been met.
- 06 Nov 2007 Status changed from in progress to completed.
- 31 Oct 2005 New trial record.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History